Pegcetacoplan (Empaveli)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegcetacoplan (Empaveli), covering 2025-02-07 to 2025-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN [Phase 2]